510(k) K223679
K223679 is an FDA 510(k) premarket notification submitted by Beckman Coulter, Inc. for the device "Access AMH". The FDA issued a decision of Substantially Equivalent on Feb 3, 2023. The device falls under product code PQO (Anti-Müllerian Hormone Test System), a Class II device regulated under 21 CFR 862.1092. Beckman Coulter, Inc. has 277 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 3, 2023
- Date Received
- Dec 8, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Anti-Müllerian Hormone Test System
- Device Class
- Class II
- Regulation Number
- 862.1092
- Review Panel
- TX
- Submission Type
- 510(k)
An Anti-Müllerian hormone test system is an in vitro diagnostic device intended to measure anti-Müllerian hormone in human serum and plasma. The test is intended to be used as an aid for assessing ovarian reserve in women.